CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Public Meeting on the Recommendations for Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 09/16/2026

RegulatoryNeutral
AI Analysis

Summary

The FDA announced a public meeting to discuss proposed recommendations for PDUFA reauthorization covering fiscal years 2028 through 2032.

Importance:2/10
Sentiment:
0.00
PDUFAReauthorizationFDAPublic MeetingUser Fee Act

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 24, 2026 10:32 PM

Read Original